San Diego Biotech

Biotech Directory

Oct
30

Daiichi Sankyo’s new a-fib drug heads toward FDA approval and a crowded market

Posted under Blog, Companies, Daiichi Sankyo, Diagnostics, Funding, Medical Devices, Medical Supply, Pharmaceuticals, Regulatory, Startups, Universities, Videos by Damian Garde

A panel of FDA advisers voted in favor of approving Daiichi Sankyo's irregular heartbeat treatment edoxaban, heralding its ability to break up blood clots and improving the company's odds of finally launching the drug in the U.S.

Oct
30

Big Pharma backs EU antibiotic R&D plan, Pfizer prompts Karo cuts, Advent closes £146M fund

Posted under Blog, Companies, Diagnostics, EuroBiotech Report, Europe, Funding, Medical Devices, Medical Supply, Pharmaceuticals, Startups, Universities, Videos by Nick Paul Taylor

In this week's EuroBiotech Report, a who's who of Big Pharma companies joined a European public-private consortium to develop and test new economic models of antibiotic R&D with the goal of making antibiotic R&D economically attractive again. And more.

Oct
30

Need for Patent Reform May be Overblown

Posted under Blog, Companies, Diagnostics, Funding, IP, Medical Devices, Medical Supply, Patent Reform, Patent troll, Patently BIOtech, Pharmaceuticals, Public Policy, Startups, Unified Patents, Universities, Videos by biotechnow@bio.org (Biotechnology Industry Organization) Patently BIOtech

Amid the cacophony of calls for patent reform legislation, mounting evidence demonstrates patent trolling may be on the wane.

As we reported earlier this month, the number of new patent cases filed in federal court has dropped by an astonishing 40 percent as compared to this time last year. A new data analysis by Unified Patents data shows more signs that patent troll suits are in decline.

Image Credit: Unified Patents

Image Credit: Unified Patents

Oct
30

Shining A Light on Lung Cancer

Posted under Blog, Christopher Davis, Companies, Diagnostics, Funding, Health, lung cancer, Lung Cancer Alliance, Lung Cancer Awareness Month, Medical Devices, Medical Supply, Pharmaceuticals, Shine a Light, Shine a Light on Lung Cancer, Startups, Universities, Videos by biotechnow@bio.org (Biotechnology Industry Organization)

Lung cancer is the leading cause of cancer death in the US, taking the lives of twice as many women as breast cancer and three times as many men as prostate cancer. While a history of smoking is the main risk factor for developing lung cancer, nearly 80% of those diagnosed today were never smokers or are former smokers who quit decades ago.

Shine-A-Light

November is Lung Cancer Awareness Month, a time of reflection for advocates and survivors across the entire spectrum of the disease. To shed some much needed attention on lung cancer, Lung Cancer Alliance hosts Shine a Light on Lung Cancer events across the country each November. Now in its sixth year, over 200 events are slated to take place on or around November 13, 2014.

Shine a Light on Lung Cancer provides the lung cancer community with hope, inspiration and support for those impacted by lung cancer and those at risk—from survivors to the newly diagnosed and from healthcare professionals to those simply wanting to help. Programs range from the latest advancements in lung cancer treatment to personal anecdotes from survivors. The goal is to connect communities impacted by lung cancer and remind individuals that they are not alone.

Shine a Light is a free event benefiting Lung Cancer Alliance, the leading non-profit organization dedicated to saving lives and advancing research by empowering those living with and at risk for lung cancer. These events unite the lung cancer community and educate the public about the impact of this deadly killer. Raising awareness is a key component in helping people get diagnosed sooner to save more lives.

Join your local community this November at a Shine a Light event. For more information visit www.ShineaLightonLungCancer.org or www.lungcanceralliance.org

 

Christopher Davis, Media Relations Manager, Lung Cancer Alliance